Insider Transactions in Q2 2021 at Century Therapeutics, Inc. (IPSC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
100,000
+12.28%
|
$2,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
614,095
+50.0%
|
-
|
|
Jun 22
2021
|
Versant Venture Capital Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
9,936,011
+43.48%
|
-
|
|
Jun 22
2021
|
Aktiengesellschaft Bayer > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
750,000
+5.59%
|
$15,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Aktiengesellschaft Bayer > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
11,925,838
+30.7%
|
-
|
|
Jun 22
2021
|
Fujifilm Cellular Dynamics, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,974,404
+36.36%
|
-
|
|
Jun 22
2021
|
Eli Casdin Director |
BUY
Open market or private purchase
|
Indirect |
750,000
+18.96%
|
$15,000,000
$20.0 P/Share
|
|
Jun 22
2021
|
Eli Casdin Director |
BUY
Conversion of derivative security
|
Indirect |
2,456,380
+50.0%
|
-
|